Cargando…
Astragalus Polysaccharide Injection (PG2) Normalizes the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Lung Cancer Receiving Immunotherapy
OBJECTIVES: The neutrophil-to-lymphocyte ratio (NLR) is a prognostic marker in patients with cancer receiving immunotherapy. Recent studies have shown that a high NLR was associated with a poor response and decreased survival. However, there is no intervention to reverse abnormally high NLR and impr...
Autores principales: | Tsao, Shih Ming, Wu, Tz Chin, Chen, JiZhen, Chang, Feichi, Tsao, Thomos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890706/ https://www.ncbi.nlm.nih.gov/pubmed/33583212 http://dx.doi.org/10.1177/1534735421995256 |
Ejemplares similares
-
Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects
por: Lee, Chia-Yin, et al.
Publicado: (2023) -
The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022) -
Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels
por: Yu, Zugong, et al.
Publicado: (2017) -
Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study
por: Wang, Cheng-Hsu, et al.
Publicado: (2019) -
Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis
por: Jin, Jing, et al.
Publicado: (2020)